HVC
IRWD icon

Healthcare Value Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Healthcare Value Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.61M Hold
200,000
– – 5.16% 11
2021
Q2 		$2.57M Hold
200,000
– – 5.13% 9
2021
Q1 		$2.24M Buy
+200,000
New +$2.11M 4.98% 9

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Healthcare Value Capital's IRWD Position: Q3 2021 in Review

Healthcare Value Capital held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2021 at 200,000 shares worth $2.61M. The position accounts for 5.16% of the portfolio, ranked #11.

Healthcare Value Capital first reported a position in IRWD in Q1 2021 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

  • Healthcare Value Capital held 200,000 shares of Ironwood Pharmaceuticals worth $2.61M as of Q3 2021.
  • Healthcare Value Capital left its Ironwood Pharmaceuticals share count unchanged in Q3 2021.
  • Ironwood Pharmaceuticals made up 5.16% of Healthcare Value Capital's portfolio in Q3 2021, its #11 holding.
  • Healthcare Value Capital first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.